Efficacy and Safety of Adjunctive Cilostazol to Dual Antiplatelet Therapy After Stent Implantation: An Updated Meta-Analysis of Randomized Controlled Trials

Conclusions:
When compared to the currently recommended DAT, triple antiplatelet therapy with cilostazol can reduce repeat revascularization with no increase in the risk of bleeding.

Source: Journal of Cardiovascular Pharmacology and Therapeutics - April 11, 2013 Category: Cardiology Authors: Ding, X. L., Xie, C., Jiang, B., Gao, J., Zhang, L. L., Zhang, H., Zhang, J. J., Miao, L. Y. Tags: Clinical Studies Source Type: research